Research Progress on the Correlation between Different Dietary Patterns and Hyperuricemia Mediated by Intestinal Flora

Abstract

Abstract: Hyperuricemia (HUA) is a disorder of purine metabolism caused by the imbalance of uric acid production and excretion, which can lead to gout and renal function damage in severe cases. At present, the prevalence of HUA/gout in China is increasing and the HUA/gout patients are younger and younger. In recent years, studies have shown that the intestinal flora of patients with HUA/gout is imbalance compared with that of healthy people, and different dietary patterns will affect the level of uric acid by adjusting the intestinal flora. This paper elaborated on the characteristics of intestinal flora of patients with HUA/gout, the effects of intestinal flora on uric acid metabolism, which laid a theoretical foundation for prevention, early diagnosis and auxiliary treatment of HUA/gout. This paper also summarizedand the impact of different dietary patterns on uric acid level, which guided patients to effectively prevent and delay the occurrence of HUA/gout by adjusting their diet patterns.

Key words: Hyperuricemia, gout, intestinal flora, dietary patterns

CLC Number:

Han Lu Shi-Jie WANG. Research Progress on the Correlation between Different Dietary Patterns and Hyperuricemia Mediated by Intestinal Flora[J]. FOOD SCIENCE, 0, (): 0-0.

References

[1] WOONG Jung Su, SU-MI Kim, GYUN Kim Yang, et al. Uric acid and inflammation in kidney disease [J]. American journal of physiology, 2020, 318(302): 1327-40,doi:10.1152/ajprenal.00272.2019.
[2] ESCHE Jonas, KRUPP Danika, MENSINK Gert Bm, et al. Estimates of renal net acid excretion and their relationships with serum uric acid and hyperuricemia in a representative German population sample [J]. European Journal of Clinical Nutrition, 2020, 74(Suppl 1): 63-8,doi:10.1038/s41430-020-0688-2.
[3] LU Jie, DALBETH Nicola, YIN Huiyong, et al. Mouse models for human hyperuricaemia: a critical review. [J]. Nature reviews Rheumatology, 2019, 15(7): 413-26,doi:10.1038/s41584-019-0222-x.
[4] YIN Hui, LIU Na, CHEN Jie. The Role of the Intestine in the Development of Hyperuricemia [J]. Frontiers in Immunology, 2022, 13: 845684,doi:10.3389/fimmu.2022.845684.
[5] HSIEH Cheng Yang , LIN Huey Juan, CHEN Chih Hung, et al. Chronic Kidney Disease and Stroke [J]. Lancet Neurol, 2014, 13(11): 1071,doi:10.1016/S1474-4422(14)70199-1.
[6] 王镜岩. 生物化学下册 [M]. 高等教育出版社, 2002.
[7] BORGHI Claudio, AGABITI-ROSEI Enrico, JOHNSON Richard J., et al. Hyperuricaemia and gout in cardiovascular, metabolic and kidney disease [J]. European Journal of Internal Medicine, 2020, 80: 1-11,doi:10.1016/j.ejim.2020.07.006.
[8] TAI Linging, LIU Zenghui, SUN Minghui, et al. Anti-hyperuricemic effects of three theaflavins isolated from black tea in hyperuricemic mice [J]. Journal of Functional Foods, 2020, 66: 103803,doi:10.1016/j.jff.2020.103803.
[9] GUO Z., ZHANG J., WANG Z., et al. Intestinal Microbiota Distinguish Gout Patients from Healthy Humans [J]. Scientific Reports 2016, 6(1): 20602,doi:10.1038/srep20602.
[10] SHAO Tiejuan, SHAO Li, LI Haichang, et al. Combined Signature of the Fecal Microbiome and Metabolome in Patients with Gout [J]. Frontiers in Microbiology, 2017, 8(578527): 268,doi:10.3389/fmicb.2017.00268.
[11] LIN Suxian, ZHANG Tao, ZHU Lingxiao, et al. Characteristic dysbiosis in gout and the impact of a uric acid-lowering treatment, febuxostat on the gut microbiota. [J]. Journal of Genetics and Genomics, 2021, 48(9): 781-91,doi:doi.org/10.1016/j.jgg.2021.06.009.
[12] CHU YongLiang, SUN Silong, HUANG Yufen, et al. Metagenomic analysis revealed the potential role of gut microbiome in gout [J]. npj Biofilms and Microbiomes, 2021, 7: 66,doi:10.1038/s41522-021-00235-2.
[13] WEI Jie, ZHANG Yuqing, DALBETH Nicola, et al. Association between gut microbiota and elevated serum urate in two independent cohorts. [J]. Arthritis & rheumatology 2021, 74(4): 682–91,doi:10.1002/art.42009.
[14] CAO Cheng, FAN Bo, ZHU Jin, et al. Association of Gut Microbiota and Biochemical Features in a Chinese Population With Renal Uric Acid Stone [J]. Frontiers in Pharmacology, 2022, 13: 888883,doi:10.3389/fphar.2022.888883.
[15] ORLANDO MéndezSalazar Eder, JANITZIA VázquezMellado, S CasimiroSoriguer Carlos, et al. Taxonomic variations in the gut microbiome of gout patients with and without tophi might have a functional impact on urate metabolism. [J]. Mol Med Today, 2021, 27: 50,doi:10.1186/s10020-021-00311-5.
[16] KI Park Han, JIN Lee Sang. Treatment of gouty arthritis is associated with restoring the gut microbiota and promoting the production of short-chain fatty acids [J]. Arthrit Res Ther, 2022, 24(1): 51,doi:10.1186/s13075-022-02742-9.
[17] YUAN Xin, CHEN Ruimin, ZHANG Ying, et al. Altered Gut Microbiota in Children With Hyperuricemia [J]. Frontiers in Endocrinology, 2022, 13: 848715,doi:10.3389/fendo.2022.848715.
[18] YANG HaiTao, XIU WenJuan, LIU JingKun, et al. Gut Microbiota Characterization in Patients with Asymptomatic Hyperuricemia: probiotics increased. [J]. Bioengineered, 2021, 12(1): 7263-75,doi:DOI:10.1080/21655979.2021.1976897.
[19] XING Shichao, MENG Dongmei, CHEN Ying, et al. Study on the Diversity of Bacteroides and Clostridium in Patients with Primary Gout [J]. Cell Biochemistry Biophysics, 2015, 71(2): 707-15,doi:10.1007/s12013-014-0253-5.
[20] 纪泽敏, 牟菲, 陈姝琴, et al. 基于倾向性评分匹配法筛选高尿酸血症的差异核心菌群 [J]. 实用医学杂志, 2020, 36(2): 6.
[21] 孙超, 王健, 王信, et al. 高尿酸血症患者肠道菌群特征分析 [J]. 淮海医药, 2022, 40(3): 279-82.
[22] WON Kim Hye, EUNJEONG Yoon, HOON Jeong Seok, et al. Distinct Gut Microbiota in Patients with Asymptomatic Hyperuricemia: A Potential Protector against Gout Development. [J]. Yonsei medical journal, 2022, 63(3): 241-51,doi:10.3349/ymj.2022.63.3.241.
[23] 于婷婷, 程翅, 喻田. 尿酸肠道代谢的研究现状 [J]. 中国临床药理学杂志, 2021, 37(21): 4.
[24] XI Hualin, SCHNEIDER Barbara L, REITZER Larry. Purine catabolism in Escherichia coli and function of xanthine dehydrogenase in purine salvage. [J]. J Bacteriol, 2000, 182(19): 5332–41,doi:doi:10.1128/JB.182.19.5332-5341.2000.
[25] WU Xiangwei, LEE Chengchi, MUZNY Donna M, et al. Urate oxidase: primary structure and evolutionary implications. [J]. Proceedings of the National Academy of Sciences of the United States of America, 1989, 86(23): 9412-6,doi:doi: 10.1073/pnas.86.23.9412.
[26] N. YAMADA C, IWAMOTO H , KANO N, et al. Evaluation of purine utilization by Lactobacillus gasseri strains with potential to decrease the absorption of food-derived purines in the human intestine [J]. Nucleosides, Nucleotides & Nucleic Acids,, 2016, 35: 10-2，670-6,doi:10.1080/15257770.2015.1125000.
[27] PAN Libin, HAN Pei, MA Shurong, et al. Abnormal metabolism of gut microbiota reveals the possible molecular mechanism of nephropathy induced by hyperuricemia [J]. Acta Pharmaceutica Sinica B, 2020, 10(2): 249-61,doi:10.1016/j.apsb.2019.10.007.
[28] KEENAN R T. The biology of urate [J]. Seminars in Arthritis Rheumatism, 2020, 50(3): S2-S10,doi:10.1016/j.semarthrit.2020.04.007.
[29] HIROTAKA Matsuo, TOMOYUKI Tsunoda, KEIKO Ooyama, et al. Hyperuricemia in acute gastroenteritis is caused by decreased urate excretion via ABCG2. [J]. Scientific reports 2016, 6(1): 31003,doi:10.1038/srep31003.
[30] HAN Jiaojiao, WANG Ziyan, LU Chenyang, et al. Correction: The gut microbiota mediates the protective effects of anserine supplementation on hyperuricaemia and associated renal inflammation. [J]. Food & function, 2022, 13(2): 1027,doi: doi: 10.1039/d1fo90120f.
[31] HAIXIAO Shang , JIA Sun , YONG Q. CHEN, et al. Clostridium Butyricum CGMCC0313.1 Modulates Lipid Profile, Insulin Resistance and Colon Homeostasis in Obese Mice [J]. Plos One, 2016, 11(4): e0154373,doi:10.1371/journal.pone.0154373.
[32] XIE Qiu-Shi, ZHANG Jia-Xin, LIU Ming, et al. Short-chain fatty acids exert opposite effects on the expression and function of p-glycoprotein and breast cancer resistance protein in rat intestine. [J]. Acta pharmacologica Sinica, 2021, 42(3): 470-81,doi:10.1038/s41401-020-0402-x.
[33] 朱学鑫, 孙益. 基于肠道菌群防治高尿酸血症的研究进展 [J]. 蛇志, 2021, 33(2): 4.
[34] SIVAPRAKASAM Sathish, PRASAD Puttur D., SINGH Nagendra Benefits of short-chain fatty acids and their receptors in inflammation and carcinogenesis [J]. Pharmacology Therapeutics, 2016, 164: 144-51,doi:10.1016/j.pharmthera.2016.04.007.
[35] MOHAMMAD Shireen, THIEMERMANN Christoph. Role of Metabolic Endotoxemia in Systemic Inflammation and Potential Interventions [J]. Frontiers in Immunology, 2021, 11: 594150,doi:doi:10.3389/fimmu.2020.594150.
[36] GUO Yingjie, YU Yanan, LI Hailong, et al. Inulin supplementation ameliorates hyperuricemia and modulates gut microbiota in Uox -knockout mice [J]. European Journal of Nutrition, 2020, 60(prepublish),doi:10.1007/s00394-020-02414-x.
[37] D Holscher Hannah. Dietary fiber and prebiotics and the gastrointestinal microbiota. [J]. Gut microbes, 2017, 8(2),doi:10.1080/19490976.2017.1290756.
[38] YU Yiran, LIU Qiuping, LI Haichang, et al. Alterations of the Gut Microbiome Associated With the Treatment of Hyperuricaemia in Male Rats [J]. Frontiers in Microbiology, 2018, 9: 2233,doi:10.3389/fmicb.2018.02233.
[39] YANYANZHU, PANDYA Bhavik J, CHOI Hyon K. Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008. [J]. Arthritis and rheumatism, 2011, 63(10),doi:10.1002/art.30520.
[40] ABHIJEET Danve, TEJ Sehra Shiv, TUHINA Neogi. Role of diet in hyperuricemia and gout. [J]. Best practice & research Clinical rheumatology, 2021, 35(4),doi:10.1016/J.BERH.2021.101723.
[41] HUANG E Y, DEVKOTA S, MOSCOSO D, et al. The role of diet in triggering human inflammatory disorders in the modern age [J]. Microbes Infection and Immunity, 2013, 15(12): 765-74,doi:10.1016/j.micinf.2013.07.004.
[42] 张彦, 张双庆. 肠道微生物组与健康 [M]. 中国轻工业出版社, 2021.
[43] ZHANG Chenhong, ZHANG Menghui, WANG Shengyue, et al. Interactions between gut microbiota, host genetics and diet relevant to development of metabolic syndromes in mice [J]. The ISME Journal, 2010, 4: 232-41,doi:10.1038/ismej.2009.112.
[44] CAO Tong, LI Xiaoyu, MAO Tao, et al. Probiotic therapy alleviates hyperuricemia in C57BL/6 mouse model [J]. Biomedical Research, 2017, 28(5): 2244-9, https://www.biomedres.info/biomedical-research/probiotic-therapy-alleviates-hyperuricemia-in-c57bl6-mouse-model.pdf.
[45] GRANT D. BRINKWORTH Manny Noakes, Peter M. Clifton, BIRD Anthony R. Comparative effects of very low-carbohydrate, high-fat and high-carbohydrate, low-fat weight-loss diets on bowel habit and faecal short-chain fatty acids and bacterial populations [J]. British Journal of Nutrition, 2009, 101(10): 1493-502,doi:10.1017/S0007114508094658.
[46] DUNCAN Sylvia H., ALVARO Belenguer, HOLTROP, et al. Reduced Dietary Intake of Carbohydrates by Obese Subjects Results in Decreased Concentrations of Butyrate and Butyrate-Producing Bacteria in Feces [J]. Applied Environmental Microbiology, 2007, 73(4): 1073-8,doi:doi: 10.1128/AEM.02340-06.
[47] RUSSELL W R, GRATZ S W, DUNCAN S H, et al. High-protein, reduced-carbohydrate weight-loss diets promote metabolite profiles likely to be detrimental to colonic health [J]. Am J Clin Nutr, 2011, 93(5): 1062-72,doi:10.3945/ajcn.110.002188.
[48] 赵仕诚, 谢军. 不同膳食常量营养素影响下的肠道菌群 [J]. 中国现代医生, 2022, 60(25): 5.
[49] MARTíNEZ Inés, KIM Jaehyoung, DUFFY Patrick R, et al. Resistant Starches Types 2 and 4 Have Differential Effects on the Composition of the Fecal Microbiota in Human Subjects [J]. Plos One, 2010, 5(11): e15046,doi:10.1371/journal.pone.0015046.
[50] GONG Lingxiao, CAO Wenyan, CHI Hailin, et al. Whole cereal grains and potential health effects: Involvement of the gut microbiota [J]. Food Res Int, 2018, 103: 84-102,doi:10.1016/j.foodres.2017.10.025.
[51] CANDELA Marco, BIAGI Elena, SOVERINI Matteo, et al. Modulation of gut microbiota dysbioses in type 2 diabetic patients by macrobiotic Ma-Pi 2 diet [J]. British Journal of Nutrition, 2016, 116(01): 1-14,doi:10.1017/S0007114516001045.
[52] KRAUTKRAMER K A, FAN J, BCKHED F. Gut microbial metabolites as multi-kingdom intermediates [J]. Nature Reviews Microbiology, 2020, 19(2): 77-94,doi:10.1038/S41579-020-0438-4.
[53] 任彩君, 吴黎明, 王凯. 膳食多酚对肠道菌群影响研究进展 [J]. 食品工业科技, 2022, 43(1): 10.
[54] 曾霓. 四种黄酮类化合物对黄嘌呤氧化酶的抑制作用及机制研究 [D]; 南昌大学, 2020.
[55] H Smith Alexandra, ERWIN Zoetendal, I Mackie Roderick. Bacterial mechanisms to overcome inhibitory effects of dietary tannins. [J]. Microb Ecol Health Dis, 2005, 50(2): 197-205,doi:10.1007/s00248-004-0180-x.
[56] DOLARA P, LUCERI C, FILIPPO C D, et al. Red wine polyphenols influence carcinogenesis, intestinal microflora, oxidative damage and gene expression profiles of colonic mucosa in F344 rats [J]. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, 2005, 591(1-2): 237-46,doi:10.1016/j.mrfmmm.2005.04.022.
[57] ASHAOLU T J. Soy bioactive peptides and the gut microbiota modulation [J]. Applied Microbiology Biotechnology Advances, 2020, 104(21): 9009-17,doi:10.1007/s00253-020-10799-2.
[58] HAJARA Aslam, WOLFGANG Marx, TETYANA Rocks, et al. The effects of dairy and dairy derivatives on the gut microbiota: a systematic literature review [J]. Gut Microbes, 2020, 12(1),doi:10.1080/19490976.2020.1799533.
[59] RACKERBY B, KIM H J, DALLAS D C, et al. Understanding the effects of dietary components on the gut microbiome and human health [J]. Food science and biotechnology 2020, 29(11): 1463-74,doi:10.1007/s10068-020-00811-w.
[60] PATTERSON E, DOHERTY Rm O, MURPHY E F, et al. Impact of dietary fatty acids on metabolic activity and host intestinal microbiota composition in C57BL/6J mice [J]. The British Journal of Nutrition, 2014, 111(11): 1905-17,doi:10.1017/S0007114514000117.
[61] AMRITA Vijay, STUART Astbury, CAROLINE Le Roy, et al. The prebiotic effects of omega-3 fatty acid supplementation: A six-week randomised intervention trial [J]. Gut Microbes, 2020, 13(1): 1-11,doi:10.1080/19490976.2020.1863133.
[62] CARIELLO M, CONTURSI A, GADALETA R M, et al. Extra-Virgin Olive Oil from Apulian Cultivars and Intestinal Inflammation [J]. Nutrients, 2020, 12(4): 1084,doi:10.3390/nu12041084.
[63] HIROMI Sato, SHINTARO Narita, MASANORI Ishida, et al. Specific Gut Microbial Environment in Lard Diet-Induced Prostate Cancer Development and Progression [J]. International Journal of Molecular Sciences, 2022, 23(4): 2214,doi:10.3390/IJMS23042214.
[64] FALONY Gwen, JOOSSENS Marie, VIEIRA-SILVA Sara, et al. Population-level analysis of gut microbiome variation [J]. Science, 2016, 352(6285): 560-4,doi:10.1126/science.aad3503.
[65] CHOI Hyon K, ATKINSON Karen, KARLSON Elizabeth W, et al. Alcohol intake and risk of incident gout in men: a prospective study [J]. The Lancet, 2004, 363(9417),doi:10.1016/S0140-6736(04)16000-5.
[66] JULIE Stamostergiou, XENOPHON Theodoridis, VASILIKI Ganochoriti, et al. The role of the Mediterranean diet in hyperuricemia and gout. [J]. Mediterranean journal of rheumatology, 2018, 29(1),doi:10.31138/mjr.29.1.21.
[67] CHIO Yokose, NATALIE McCormick, K Rai Sharan, et al. Effects of Low-Fat, Mediterranean, or Low-Carbohydrate Weight Loss Diets on Serum Urate and Cardiometabolic Risk Factors: A Secondary Analysis of the Dietary Intervention Randomized Controlled Trial (DIRECT). [J]. Diabetes care, 2020, 43(11),doi:10.2337/dc20-1002.
[68] MELINI Valentina, MELINI Francesca. Gluten-Free Diet: Gaps and Needs for a Healthier Diet [J]. Nutrients, 2019, 11(1): 170,doi:10.3390/nu11010170.
[69] TANPOWPONG Pornthep, BRODER-FINGERT Sarabeth, KATZ Aubrey J, et al. Predictors of Gluten Avoidance and Implementation of a Gluten-Free Diet in Children and Adolescents without Confirmed Celiac Disease [J]. The Journal of Pediatrics, 2012, 161(3): 1-2,doi:10.1016/j.jpeds.2012.02.049.
[70] PALMA Giada De, NADAL Inmaculada, MARIA Carmen Collado, et al. Effects of a gluten-free diet on gut microbiota and immune function in healthy adult human subjects [J]. The British journal of nutrition, 2009, 102(8): 1154-60,doi:10.1017/S0007114509371767.
[71] STAUDACHER H M, LOMER M C E, ANDERSON J L, et al. Fermentable carbohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome [J]. The Journal of Nutrition, 2012, 142(8): 1510-8,doi: 10.3945/jn.112.159285.
[72] HALMOS E P, CHRISTOPHERSEN C T, BIRD A R, et al. Consistent Prebiotic Effect on Gut Microbiota With Altered FODMAP Intake in Patients with Crohn's Disease: A Randomised, Controlled Cross-Over Trial of Well-Defined Diets [J]. Clinical Translational Gastroenterology, 2016, 7(4): e164,doi:10.1038/ctg.2016.22.
[73] 赵科静, 王喜娟, 王佳佩. 低FODMAP饮食对溃疡性结肠炎患儿营养状况,炎性细胞因子水平及肠道菌群的影响价值 [J]. 医学理论与实践, 2022, 35(21): 3.
[74] HALMOS E P, CHRISTOPHERSEN C T, BIRD A R, et al. Diets that differ in their FODMAP content alter the colonic luminal microenvironment [J]. Gut Microbes, 2015, 64(1): 93-100,doi:10.1136/gutjnl-2014-307264.